TSHA Q1 2026 Earnings WiderthanExpected Loss as Company Continues Development Pipeline CLBK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues NICE Q1 2026 Earnings EPS Beats Estimates Amid Cloud Momentum Stock Edges Lower Metallus MTUS Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Headwinds CLPT Q1 2026 Earnings EPS Misses Estimates as ClearPoint Neuro Continues Strategic Investments